The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021 at 08:13 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...